ACSM4 | Acyl-CoA synthetase medium-chain family member 4 | Enzymes Mitochondrial proteins Predicted membrane proteins
| | | | | Not detected |
ACSM5 | Acyl-CoA synthetase medium-chain family member 5 | Enzymes Mitochondrial proteins
| | | | | Tissue enriched |
ACTL10 | Actin-like 10 | Predicted secreted proteins
| | | | | Tissue enriched |
ACTL7B | Actin-like 7B | | | | | | Tissue enriched |
ACTL8 | Actin-like 8 | Cytoskeleton related proteins
| | | | | Tissue enriched |
ACTR3B | ARP3 actin-related protein 3 homolog B (yeast) | Cytoskeleton related proteins
| | | | | Expressed in all |
ACTR3C | ARP3 actin-related protein 3 homolog C (yeast) | | | | | | Mixed |
ACTRT1 | Actin-related protein T1 | Cytoskeleton related proteins
| | | | | Tissue enriched |
ACTRT2 | Actin-related protein T2 | Cytoskeleton related proteins
| | | | | Tissue enriched |
ACTRT3 | Actin-related protein T3 | Cytoskeleton related proteins
| | | | | Tissue enriched |
ADAD1 | Adenosine deaminase domain containing 1 (testis-specific) | | | | | | Tissue enriched |
ADAD2 | Adenosine deaminase domain containing 2 | | | | | | Tissue enriched |
ADAL | Adenosine deaminase-like | | | | | | Expressed in all |
ADAM11 | ADAM metallopeptidase domain 11 | Enzymes Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
ADAM18 | ADAM metallopeptidase domain 18 | Enzymes Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enriched |
ADAM20 | ADAM metallopeptidase domain 20 | Enzymes Predicted membrane proteins
| | | | | Tissue enriched |
ADAM21 | ADAM metallopeptidase domain 21 | Enzymes Predicted membrane proteins
| | | | | Tissue enriched |
ADAM28 | ADAM metallopeptidase domain 28 | Enzymes Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
ADAM30 | ADAM metallopeptidase domain 30 | Enzymes Plasma proteins Predicted membrane proteins
| | | | | Tissue enriched |
ADAMTS14 | ADAM metallopeptidase with thrombospondin type 1 motif, 14 | Cancer-related genes Enzymes Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
ADAMTS15 | ADAM metallopeptidase with thrombospondin type 1 motif, 15 | Enzymes Predicted secreted proteins
| | | | | Tissue enhanced |
ADAMTS16 | ADAM metallopeptidase with thrombospondin type 1 motif, 16 | Enzymes Predicted secreted proteins
| | | | | Tissue enhanced |
ADAMTS17 | ADAM metallopeptidase with thrombospondin type 1 motif, 17 | Disease related genes Enzymes Potential drug targets Predicted secreted proteins
| | | | | Mixed |
ADAMTS19 | ADAM metallopeptidase with thrombospondin type 1 motif, 19 | Enzymes Predicted secreted proteins
| | | | | Group enriched |
ADAMTS2 | ADAM metallopeptidase with thrombospondin type 1 motif, 2 | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted secreted proteins
| | | | | Mixed |
ADAMTS20 | ADAM metallopeptidase with thrombospondin type 1 motif, 20 | Cancer-related genes Enzymes Predicted secreted proteins
| | | | | Not detected |
ADAMTS3 | ADAM metallopeptidase with thrombospondin type 1 motif, 3 | Cancer-related genes Enzymes Predicted secreted proteins
| | | | | Mixed |
ADAMTS6 | ADAM metallopeptidase with thrombospondin type 1 motif, 6 | Cancer-related genes Enzymes Predicted secreted proteins
| | | | | Tissue enhanced |
ADAMTS8 | ADAM metallopeptidase with thrombospondin type 1 motif, 8 | Cancer-related genes Enzymes Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
ADAMTSL3 | ADAMTS-like 3 | Predicted secreted proteins
| | | | | Mixed |
ADAMTSL4-AS1 | ADAMTSL4 antisense RNA 1 | | | | | | Not detected |
ADC | Arginine decarboxylase | Enzymes
| | | | | Tissue enhanced |
ADCK1 | AarF domain containing kinase 1 | Enzymes Predicted secreted proteins
| | | | | Expressed in all |
ADCK2 | AarF domain containing kinase 2 | Enzymes Predicted membrane proteins
| | | | | Expressed in all |
ADCK5 | AarF domain containing kinase 5 | Enzymes Predicted membrane proteins
| | | | | Expressed in all |
ADCY7 | Adenylate cyclase 7 | Enzymes Predicted membrane proteins
| | | | | Expressed in all |
ADGB | Androglobin | Enzymes
| | | | | Group enriched |
ADH6 | Alcohol dehydrogenase 6 (class V) | Enzymes
| | | | | Tissue enriched |
ADIG | Adipogenin | Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enriched |
ADM2 | Adrenomedullin 2 | Predicted secreted proteins
| | | | | Tissue enhanced |
ADM5 | Adrenomedullin 5 (putative) | Predicted secreted proteins
| | | | | Mixed |
ADORA2B | Adenosine A2b receptor | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Mixed |
ADORA3 | Adenosine A3 receptor | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
ADPRHL1 | ADP-ribosylhydrolase like 1 | | | | | | Group enriched |
ADRA1D | Adrenoceptor alpha 1D | FDA approved drug targets G-protein coupled receptors Plasma proteins Predicted membrane proteins
| | | | | Tissue enhanced |
ADRA2C | Adrenoceptor alpha 2C | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
ADRB3 | Adrenoceptor beta 3 | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
ADSSL1 | Adenylosuccinate synthase like 1 | Enzymes Plasma proteins
| | | | | Tissue enriched |
ADTRP | Androgen-dependent TFPI-regulating protein | Predicted membrane proteins
| | | | | Tissue enhanced |
AFMID | Arylformamidase | Enzymes
| | | | | Expressed in all |